These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26618363)

  • 1. Do patient or provider characteristics impact management of diabetes?
    LeBlanc ES; Rosales AG; Kachroo S; Mukherjee J; Funk KL; Nichols GA
    Am J Manag Care; 2015 Sep; 21(9):597-606. PubMed ID: 26618363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an Electronic Medical Record (EMR) to Identify Glycemic Intensification Strategies in Type 2 Diabetes.
    Korytkowski MT; Brooks M; Lombardero M; DeAlmeida D; Kanter J; Magaji V; Orchard T; Siminerio L
    J Diabetes Sci Technol; 2015 May; 9(3):593-601. PubMed ID: 25526759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).
    McEwen LN; Bilik D; Johnson SL; Halter JB; Karter AJ; Mangione CM; Subramanian U; Waitzfelder B; Crosson JC; Herman WH
    Diabetes Care; 2009 Jun; 32(6):971-6. PubMed ID: 19228862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic response to newly initiated diabetes therapies.
    Karter AJ; Moffet HH; Liu J; Parker MM; Ahmed AT; Go AS; Selby JV
    Am J Manag Care; 2007 Nov; 13(11):598-606. PubMed ID: 17988185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
    Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antidiabetic medication adherence and glycemic control in managed care.
    Rozenfeld Y; Hunt JS; Plauschinat C; Wong KS
    Am J Manag Care; 2008 Feb; 14(2):71-5. PubMed ID: 18269302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
    Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
    Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.
    Cook MN; Girman CJ; Stein PP; Alexander CM; Holman RR
    Diabetes Care; 2005 May; 28(5):995-1000. PubMed ID: 15855556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus.
    Alonso-Fernández M; Mancera-Romero J; Mediavilla-Bravo JJ; Comas-Samper JM; López-Simarro F; Pérez-Unanua MP; Iturralde-Iriso J;
    Prim Care Diabetes; 2015 Oct; 9(5):385-91. PubMed ID: 25686480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with intensification of oral diabetes medications in primary care provider-patient dyads: a cohort study.
    Bolen SD; Bricker E; Samuels TA; Yeh HC; Marinopoulos SS; McGuire M; Abuid M; Brancati FL
    Diabetes Care; 2009 Jan; 32(1):25-31. PubMed ID: 18931096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.
    Grant R; Adams AS; Trinacty CM; Zhang F; Kleinman K; Soumerai SB; Meigs JB; Ross-Degnan D
    Diabetes Care; 2007 Apr; 30(4):807-12. PubMed ID: 17259469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
    Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
    JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of basal and prandial insulin for optimal glycemic control.
    Horton ES
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S21-7. PubMed ID: 19179213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.
    Lin SD; Tsai ST; Tu ST; Su CC; Chen JF; Lu CH; Wang CH; Yu NC; Hsu SR; Hsieh MC
    Prim Care Diabetes; 2015 Apr; 9(2):135-41. PubMed ID: 25266893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data.
    Weisman A; Brown R; Chu L; Aronson R; Perkins BA
    Can J Diabetes; 2024 Feb; 48(1):44-52.e5. PubMed ID: 37717631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States.
    Durden E; Lenhart G; Lopez-Gonzalez L; Hammer M; Langer J
    J Med Econ; 2016; 19(4):403-13. PubMed ID: 26653068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding glucose-lowering agents delays insulin initiation and prolongs hyperglycemia.
    Hugie C; Waterbury NV; Alexander B; Shaw RF; Egge JA
    Am J Manag Care; 2016 Apr; 22(4):e134-40. PubMed ID: 27143349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic relapse in type 2 diabetes.
    Graber AL; Shintani AK; Wolff K; Brown A; Elasy TA
    Endocr Pract; 2006; 12(2):145-51. PubMed ID: 16690461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes.
    Desai U; Kirson NY; Kim J; Khunti K; King S; Trieschman E; Hellstern M; Hunt PR; Mukherjee J
    Diabetes Care; 2018 Oct; 41(10):2096-2104. PubMed ID: 30131396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.